Roots Analysis has done a detailed study on Gene Switch Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
Presently, close to 50 gene switch platforms are being developed for various applications in adoptive cell therapies (ACT), including CAR-Ts, TCRs and gene therapies; majority of them are protein-based gene switches
Various small molecules, including rimiducid, rapamycin and dasatinib, are being investigated to design safety switch for ACTs; management of treatment related toxicity has emerged as the key application of such platforms
